bioMérieux S.A. (EPA:BIM)

Market Cap	11.10B -18.6%
Revenue (ttm)	4.07B +2.3%
Net Income	397.50M -8.0%
EPS	3.34 -8.2%
Shares Out	118.07M
PE Ratio	28.14
Forward PE	19.85
Dividend	0.98 (1.03%)
Ex-Dividend Date	Jun 9, 2026

Volume	95,687
Average Volume	138,951
Open	95.05
Previous Close	95.05
Day's Range	93.85 - 95.25
52-Week Range	91.85 - 128.30
Beta	0.66
RSI	38.60
Earnings Date	Feb 27, 2026

About bioMérieux

bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments. The company offers CHROMID RANGE, a chromogen culture media; air, surface, and water monitoring systems; BACT/ALERT VIRTUO, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system (PCR); BIOFIRE SPOTFIRE, a lowplex PCR point-of...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1963
• Employees: 14,754
• Stock Exchange: Euronext Paris
• Ticker Symbol: BIM

Financial Performance

In 2025, bioMérieux's revenue was 4.07 billion, an increase of 2.26% compared to the previous year's 3.98 billion. Earnings were 397.50 million, a decrease of -8.03%.